The stock of Critical Outcome Technologies Inc. (CVE:COT) is a huge mover today! About 97,235 shares traded hands. Critical Outcome Technologies Inc. (CVE:COT) has risen 6.00% since September 17, 2016 and is uptrending. It has outperformed by 0.39% the S&P500.
The move comes after 8 months positive chart setup for the $77.91M company. It was reported on Oct, 17 by Barchart.com. We have $0.85 PT which if reached, will make CVE:COT worth $32.72M more.
More notable recent Critical Outcome Technologies Inc. (CVE:COT) news were published by: Benzinga.com which released: “Critical Outcome Technologies Provides Update on Recent Achievements and …” on October 14, 2016, also Marketwired.com with their article: “Critical Outcome Technologies Reports Year-End Financial & Operating Results” published on August 03, 2016, Marketwired.com published: “Critical Outcome Technologies Receives $1.6M From Warrant Exercises” on June 03, 2016. More interesting news about Critical Outcome Technologies Inc. (CVE:COT) were released by: Business.Financialpost.com and their article: “Podcast: Critical Outcome Technologies CEO Wayne Danter on new ways to develop …” published on May 31, 2016 as well as Marketwired.com‘s news article titled: “Critical Outcome Technologies Pursues Orphan Drug Designation for COTI-2 …” with publication date: December 02, 2015.
Critical Outcome Technologies Inc. is a clinical-stage biopharmaceutical company. The company has a market cap of $77.91 million. The Firm is engaged in drug discovery and development. It currently has negative earnings. The Firm uses machine learning to develop targeted therapies thereby managing the timeline and cost of getting new drug therapies to market.
COT Company Profile
Cott Corporation, incorporated on December 31, 2006, along with its subsidiaries, is engaged in the production of beverages on behalf of retailers, brand owners and distributors. The Firm operates through four divisions: DSS; Cott North America; Cott United Kingdom (Cott U.K.), and All Other, which includes its Mexico segment, Royal Crown International (RCI) segment and other miscellaneous expenses.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.